Skip to main content
< Back to news
Photo: Creatio-UB.
 01.07.2024

The Preclinical Studies Area –avantdrug– of Creatio UB is celebrating its first anniversary

This Monday marked 1 year since Creatio, a center for the production and validation of advanced therapies at the University of Barcelona, ​​inaugurated the Preclinical Studies Area –avantdrug– at the Barcelona Science Park. With extensive experience in the field, its team is dedicated to carrying out regulatory preclinical studies of products and technologies in development, allowing the center to offer support and
services throughout the all drug development, from basic research to the production.

In these 365 days, the Preclinical Studies Area – avantdrug – has maintained uninterrupted activity, carrying out 51 transfer activities with public and private entities. The continued and growing collaborations show the trust that has been placed in Creatio with this service. Consolidating Creatio a key center in the biomedical ecosystem in Catalonia and in the Spain.

The two laboratories of this area occupy a total area of 88 m2 located at the Cluster I of the Barcelona Science Park. These spaces are divided into 1 analytical laboratory and 1 histology laboratory. Moreover, the area has an additional space for freezing and access to the Park services and platforms, as well as, the services of the Scientific and Technological Centers of the University of Barcelona (CCiTUB) which complete the offer. 

» Link to the news[+]